GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Clinical trial NCT05356104 · RECRUITING
Trial details
- NCT number
- NCT05356104
- Sponsor
- Chinese University of Hong Kong
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2027-05-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.